Author

J. Rastrick

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:transcription & RNA processing· 1

Frequent Co-Authors

A. Antanaviciute· 1 shared A. White· 1 shared C. Butterworth· 1 shared C. Clelland· 1 shared C. S. Hardman· 1 shared C. Trevisan· 1 shared C. Vuppusetty· 1 shared E. Fraser· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Antanaviciute

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Extracellular matrix educates a tumor macrophage phenotype found in ovarian cancer metastasis

E. H. Puttock, E. J. Tyler, M. Manni, E. Maniati, C. Butterworth, E. Peerani, P. Hirani, V. Gauthier, Y. Liu, G. Maniscalco, V. Rajeeve, P. Cutillas, C. Trevisan, M. Pozzobon, M. Lockley, , O. M. T. Pearce

The paper shows that the tumor extracellular matrix educates macrophages to adopt a phenotype seen in ovarian cancer metastasis, affecting T cell function and immune regulation.

bioRxiv · Aug 11, 2022 · PreprintCancer Biology

Type-1 IFN primed monocytes in pathogenesis of idiopathic pulmonary fibrosis

L.-P. Ho, E. Fraser, L. Denney, K. Blirando, C. Vuppusetty, A. Antanaviciute, Y. Zheng, E. Repapi, V. Iotchkova, S. Taylor, N. Ashley, V. St Noble, R. Hoyles, R. Benamore, C. Clelland, , J. Rehwinkel

The paper identifies type-1 IFN-primed monocytes as key drivers of fibrosis in IPF, showing their increased levels, altered phenotype, and potential as therapeutic targets.

bioRxiv · Jan 16, 2020 · PreprintImmunology